ABSTRACTS SELECTED AS E-POSTERS
IN ALPHABETIC ORDER ACCORDING TO THE NAME OF THE FIRST
AUTHOR
CLINICAL POSTERS
Poster 12: AN UNEXPECTED COURSE IN MDS
Maria Eduarda Couto1, Isabel Oliveira2 and José Mariz2
Poster 13: AZACITIDINE IN MYELODYSPLASTIC SYNDROMES - 10 YEARS OF
EXPERIENCE IN AN ONCOLOGY PORTUGUESE CENTRE
Catarina Dantas Rodrigues1, Mário Sousa Pimenta2, José Guilherme Freitas2,
Ana Ribeiro Baldaia3, Luísa Lopes dos Santos3, Dulcineia Pereira2, Cláudia
Moreira2, Isabel Oliveira4, Nélson Domingues4, Ana Espirito-Santo4, Ângelo
Martins4, Ilídia Moreira4, Luisa Viterbo4, Sérgio Chacim4 and José Mariz5
Poster 14: PROGNOSTIC FACTORS AND OUTCOMES IN MYELODYSPLASTIC
SYNDROMES PATIENTS: 9-YEAR FOLLOW UP
José Freitas, Márcio Tavares, Dulcineia Pereira, Cláudia Moreira, Sérgio
Chacim, Nélson Domingues, Ana Espirito-Santo, Ângelo Martins, Isabel
Oliveira, Luisa Viterbo, Ilídia Moreira and Jose Mario Mariz
Poster 15: SPECIFIC AND ISOLATED CLONES IN MDS PATIENTS OF INDIA
DETECTED BY CONVENTIONAL CYTOGENETICS: EXPERIENCE OF A
SINGLE REFERRAL CENTER
Bani Ganguly
Poster 16: MOLECULAR BASIS AND CLINICAL IMPLICATION OF SPONTANEOUS IN
VITRO MYELOID COLONY FORMATION IN CHRONIC
MYELOMONOCYTIC LEUKEMIA
Klaus Geissler
Poster 17: REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS (RARS)
ASSOCIATED WITH HEREDITARY HEMOCHROMATOSIS (HFE) GENE
MUTATIONS: CASE PRESENTATION AND OVERVIEW
Daniela Georgescu1, Felicia Mihai1, Claudia Despan1, Geanina Ofiteru1,
Nicoleta Ilie2, Poliana Leru1, Andreescu Ana-Maria2 and Nicorescu Iuliana3
Poster 18: FRAILTY AND QUALITY OF LIFE IN OLDER PATIENTS WITH
MYELODYSPLASTIC SYNDROME: AN ANALYSIS OF SERIAL EORTC QLQ-C30
SCORES
Esther Rose Jones1, Michelle Wall1, Rakchha Chhetri1,2, Suzanne Edwards3 and
Devendra Hiwase2,4,5
SCIENTIFIC PROGRAMME
SESSION I
ETIOLOGY OF MDS
SESSION II
BIOLOGY OF MDS –
GENETIC ABNORMALITIES
SESSION III
BIOLOGY OF MDS:
STEM CELLS AND THE
MICROENVIRONMENT
SESSION IV
DIAGNOSTIC WORKUP
AND PROGNOSTIC
FACTORS IN MDS
SESSION V
SPECIFIC SUBTYPES
OF MDS, BASED ON
MORPHOLOGY AND
MOLECULAR BIOLOGY
SESSION VI
TREATMENT OF MDS
SESSION VII
CURRENT PROGRESS IN
THE TREATMENT OF MDS
SESSION VIII
FUTURE TREATMENTS
AND TREATMENT
STRATEGIES IN MDS
SESSION IX
LATE-BREAKING TALKS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
AS E-POSTERS
DISCLOSURES